OMB APPROVAL

OMB Number: 3235-0058

Expires:  April 30, 2009

Estimated average burden

Hours per response … 2.50


SEC FILE NUMBER


CUSIP NUMBER

UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549


FORM 12b-25


NOTIFICATION OF LATE FILING

 

 

 

 

 

 

(Check one):

 

oForm 10-K o  Form 20-F o  Form 11-K þ Form 10-Q  o  Form 10-D o  Form N-SAR o  Form N-CSR

 

 

 

 

 

 

  

 

For Period Ended:

 

March 31, 2009

  

 

 

 

 

 

 

 

 

 

 

 

o   Transition Report on Form 10-K

 

 

 

 

 

 

 

 

 

o   Transition Report on Form 20-F

 

 

 

 

 

 

 

 

 

o   Transition Report on Form 11-K

 

 

 

 

 

 

 

 

 

o   Transition Report on Form 10-Q

 

 

 

 

 

 

 

 

 

o   Transition Report on Form N-SAR

 

 

 

 

 

 

 

  

 

For the Transition Period Ended:

 

 

 

  

 

 

 

 

 


Read Instruction (on back page) Before Preparing Form. Please Print or Type.

Nothing in this form shall be construed to imply that the Commission has verified any information contained herein.


If the notification relates to a portion of the filing checked above, identify the Item(s) to which the notification relates:

 


 

PART I — REGISTRANT INFORMATION


Health Enhancement Products Inc.

 

Full Name of Registrant


Western Glory Hole, Inc.

 

Former Name if Applicable


7740 E. Evans Road #A101

 

Address of Principal Executive Office (Street and Number)

Scottsdale, AZ  85260

 

City, State and Zip Code






PART II — RULES 12b-25(b) AND (c)


If the subject report could not be filed without unreasonable effort or expense and the registrant seeks relief pursuant to Rule 12b-25(b), the following should be completed. (Check box if appropriate)


 

 

 

 

 

(a)

 

The reason described in reasonable detail in Part III of this form could not be eliminated without unreasonable effort or expense;

 

 

 

 


þ

(b)

 

The subject annual report, semi-annual report, transition report on Form 10-K, Form 20-F, Form 11-K, Form N-SAR or Form N-CSR, or portion thereof, will be filed on or before the fifteenth calendar day following the prescribed due date; or the subject quarterly report or transition report on Form 10-Q or subject distribution report on Form 10-D, or portion thereof, will be filed on or before the fifth calendar day following the prescribed due date; and

 

 

 

 

 

(c)

 

The accountant’s statement or other exhibit required by Rule 12b-25(c) has been attached if applicable.

 

   

PART III — NARRATIVE


State below in reasonable detail why Forms 10-K, 20-F, 11-K, 10-Q, 10-D, N-SAR, N-CSR, or the transition report or portion thereof, could not be filed within the prescribed time period.


(Attach extra Sheets if Needed)



Health Enhancement Products Inc. (the “Company”) is unable to file its Quarterly Report on Form 10-Q for the Quarter ended March 31, 2009 within the prescribed time period because the Company is completing its audited financial statements for the Form 10k for the year ended December 31, 2008,  which financial statements could have an effect on the financial information as reported on the quarterly Form 10Q.  The Company’s Form 10K is being filed today and the Company will file its Form 10Q within the prescribed time period.






















 

 

 

SEC 1344 (03-05)

 

Persons who are to respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB control number.







PART IV — OTHER INFORMATION

(1)

 

Name and telephone number of person to contact in regard to this notification

 

 

 

 

 

Janet Crance

 

480

 

385-3800

(Name)

 

(Area Code)

 

(Telephone Number)


(2)

 

Have all other periodic reports required under Section 13 or 15(d) of the Securities Exchange Act of 1934 or Section 30 of the Investment Company Act of 1940 during the preceding 12 months or for such shorter period that the registrant was required to file such report(s) been filed? If answer is no, identify report(s).

 

 

                               Yes o  No  þ  

 

 

The Company’s Form 10K for the year ended December 31, 2008 has not yet been filed.

 

 

 

(3)

 

Is it anticipated that any significant change in results of operations from the corresponding period for the last fiscal year will be reflected by the earnings statements to be included in the subject report or portion thereof?

 

 

                                                                                                                                                          Yes o     No þ

 

 

 

 

 

 

 

 

 

 

 

If so, attach an explanation of the anticipated change, both narratively and quantitatively, and, if appropriate, state the reasons why a reasonable estimate of the results cannot be made.


 

 

__________________________________________________________________________________________

 




Health Enhancement Products Inc.

 (Name of Registrant as Specified in Charter)


has caused this notification to be signed on its behalf by the undersigned hereunto duly authorized.

 

 

 

 

 

 

 

Date:

 

05/18/2009

 

By:

 

/s/ Janet L Crance

  

 

  

 

 

 

 

  

 

 

 

 

 

Chief Accounting Officer and

Chief Financial Officer